Lipid nanoparticles are transforming rare disease treatment by enabling targeted mRNA and gene therapies. Learn how nanomedicine drives personalized, point-of-care solutions. The rare disease dilemma More than 300 million people worldwide live with a rare disease. Most of them face a long diagnostic journey, limited [...]
The journey from scientific discovery to patient benefit is often long and uncertain. But in recent years, lipid nanoparticles (LNPs) have emerged as a key enabler for accelerating the clinical translation of innovative therapies, including mRNA, proteins, peptides, and gene-editing tools. At DIVERSA, we are designing next-generation nanoparticles that [...]
Nanomedicine is revolutionizing healthcare, offering groundbreaking solutions in drug delivery, diagnostics, and personalized medicine. However, while the promise of nanotechnology in medicine continues to grow, translating these innovations from the lab to the clinic is fraught with regulatory challenges. The unique properties of nanoparticles, which [...]
